IHH Healthcare invests in US medical company TibaRay to introduce new tumor radiotherapy technology | Lianhe Zaobao

IHH Healthcare strategically invests in the American medical technology company TibaRay, introducing ultra-fast, high-precision radiation therapy (FLASH) technology. This technology is 400 times faster than existing technologies, significantly shortening treatment times, reducing radiation exposure to healthy tissues, and improving patient experience. IHH's Chief Corporate Officer Pandit stated that this investment aligns with the group's transformation strategy, aiming to enhance oncology treatment capabilities and promote cutting-edge technologies in fields such as oncology, cardiology, and orthopedics. The two parties will collaborate on clinical evaluations and knowledge exchange